Iroxanadine

• Description:

  Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.CAS 번호13480-84-5

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  260.33

• Molecular Formula:

  C14H20N4O

• Notes:

  Research use only, not for human use.

• Receptor:

  P38 MAPK

• CAS Number:

  203805-20-3